• TRADE NAMES: Anamorph; Astramorph; Avinza (Ligand); Contalgin; Duramorph (Baxter, Elkins-Sinn); Epimorph; Infumorph (Baxter); Kadian (aaiPharma); Morphabond (Inspirion); Morphine-HP; MOS; Moscontin; MS Contin (Purdue); MS-IR; MS/S; MSIR Oral (Purdue); MST Continus; OMS Oral; Oramorph SR; RMS; Roxanol (aaiPharma); Sevredol; Statex
  • INDICATIONS: Severe pain, acute myocardial infarction
  • CLASS: Opiate agonist
  • HALF-LIFE: 2–4 hours

ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and INTERACTION WITH ALCOHOL

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 09/27/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric